ASPEN PHARMACARE CANADA Inc. Launches ASPEN-Dienogest for the Management of Pelvic Pain Associated With Endometriosis

Oakville, ON, April 15, 2020 – Aspen Pharmacare Canada Inc. is proud to launch ASPEN-Dienogest, a generic drug whose bioequivalence to the brand product VISANNE® has been demonstrated the management of pelvic pain associated with endometriosis.   ASPEN-Dienogest provides the same efficacy and safety as the brand product, at a lower cost to patients.

ASPEN-Dienogest is now available at pharmacies across Canada.  ASPEN-Dienogest will be listed on most provincial formularies and private insurance by June 15th. Please check your provincial plans for coverage.